New York Times bestselling author Katy Regnery returns with the second book in her Odds-Are-Good series!
Release Date: November 4
When a lonely vet(eran) and an ambitious vet(erinarian) work together to win the Qimmiq 200, sparks will fly…
Montana-born veterinary student, Juliet Sanderson, is disappointed when her project on the treatment and care of sled dogs falls through due to the illness of a local musher. In an effort to salvage her study and graduate, she answers the personal ad of Alaskan musher, Cody Garrison, who is desperately seeking a teammate for an upcoming co-ed race, The Qimmiq 200.
Cody Garrison, a retired U.S. Marine, doesn’t tell Juliet that he was left permanently disabled during his time in active service, fearing that she wouldn’t agree to race with him if she knew. But once she arrives in Alaska, discovering the truth about Cody’s past will be inevitable. Will the partnership they’ve agreed to, and the off-the-charts chemistry between them, be enough to see them through the rigors of training and secure them the win of their lives?
My Review
Get Your Copy Here:
New York Times and USA Today bestselling author Katy Regnery started her writing career by enrolling in a short story class in January 2012. One year later, she signed her first contract, and Katy’s first novel was published in September 2013.
Over forty books later, Katy claims authorship of the multititled New York Times and USA Today bestselling Blueberry Lane Series, which follows the English, Winslow, Rousseau, Story, and Ambler families of Philadelphia; the seven-book, bestselling ~a modern fairytale~ series, including Katy’s “Beauty and the Beast” story, The Vixen and the Vet, which was a 2015 RITA© nominee; and several other stand-alone novels and novellas, including the critically-acclaimed, 2018 RITA© nominated, USA Today bestselling contemporary romance, Unloved, a love story.
Katy’s books are available in English, French, German, Italian, Polish, Portuguese and Turkish.
Find Out More About Katy Regnery Here:
Hosted By:
Subscribe to:
Post Comments
(Atom)
0 comments:
Post a Comment